ConductScience.org, home

Gene · 28935

IGKV1-27: immunoglobulin kappa variable 1-27

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. IGKV1-27: immunoglobulin kappa variable 1-27. Genes, record 28935. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/28935

On this page

Gene

Symbol
IGKV1-27
HGNC
Name
immunoglobulin kappa variable 1-27
HGNC
NCBI Gene ID
28935
NCBI Gene
HGNC ID
HGNC:5735
HGNC
Ensembl
ENSG00000244575
NCBI Gene
Aliases
A20, IGKV127
NCBI Gene
Type
other
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
A0A075B6S5Immunoglobulin kappa variable 1-271170Ensembl, HGNC

Source UniProt

Patents10

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-1914255A0A075B6S5Espacenet
EP 4641203 A22025-10-29509A0A075B6S5Espacenet
JP 2025517967 A2025-06-12509A0A075B6S5Espacenet
JP 2025517970 A2025-06-1214255A0A075B6S5Espacenet
KR 1020250017230 A2025-02-04509A0A075B6S5Espacenet
US 11446398 B22022-09-2039802A0A075B6S5Espacenet
US 11446398 B22022-09-2039803A0A075B6S5Espacenet
US 11390673 B22022-07-1955A0A075B6S5Espacenet
JP 2022524081 A2022-04-27142773A0A075B6S5Espacenet
JP 2022524081 A2022-04-27142774A0A075B6S5Espacenet

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,236

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleIGKV1-27 papersNewest fiscal year
P30CA008748Cancer Center Support Grant72025
T32DK007007INRSA Training Grant in Gastroenterology72025
R01HL089221Determinants of AAV Tropism62025
P30CA016672Cancer Center Support Grant52025
P30DK026743UCSF Liver Center52025
P01CA019014Viral Oncogenesis, Latency, and Replication42025
P30DK040561Boston Area Nutrition Obesity Research Center (NORC)42025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital42025
R01AR046713Cytokine regulation of RA synoviocyte phenotype42025
P30CA016086Cancer Center Support Grant32025

1 to 10 of 1,236Source NIH's project files

See all 1,236 nih grants

Papers1,911

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Author Correction: Non-catalytic ubiquitin binding by A20 prevents psoriatic arthritis-like disease and inflammation.Nat Immunol202642773268PubTator, text miningPubMed
CRISPR/Cas9 screening revealed BIRC6-AS1/BIRC6 mediates abiraterone resistance via NHEJ pathway-dependent A20 degradation in prostate cancer.Oncogene202642754663PubTator, text miningPubMed
Editorial comment on "Functional changes in the gut microbiota are associated with the intestinal phenotype in A20 haploinsufficiency".Pediatr Allergy Immunol202642747403PubTator, text miningPubMed
In-depth examination of the zinc-mitigation of the molecular effects of heat stress-induced intestinal damage in broilers.Poult Sci202642731220PubTator, text miningPubMed
Glucose hypometabolism gates tau-dependent necroptosis.Neuron202642685677PubTator, text miningPubMed
Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-κB.JCI Insight202642579371PubTator, text miningPubMed
Compartment-specific Zinc Misallocation in Diabetic Foot Ulcers: Mechanistic Coupling Between Macrophage M1 Locking and MMP-9 Hyperactivation.Biol Trace Elem Res202642448958PubTator, text miningPubMed
Cryptic RNA binding sites are energetically accessible and chemically addressable.bioRxiv202642427657PubTator, text miningPubMed
Behçet's spectrum disorders: genetic and immunological insights into an emerging disease concept.World J Pediatr202642337193PubTator, text miningPubMed
The host ubiquitination system dynamically regulates the inflammatory response of macrophages to bacteria.Front Immunol202642199436PubTator, text miningPubMed

1 to 10 of 1,911

See all 1,911 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/28935

GET https://conductscience.org/api/genes/v1/28935/grants?page=2